NEW YORK, June 16 (GenomeWeb News) - Tm Bioscience today said that Dutch distributor Sanbio will commercialize its ID-Tag Respiratory Viral Panel in the Netherlands, which is Tm's first deal of its kind in Europe.
The panel detects and discriminates between 20 respiratory viruses including Avian Flu and SARS, Tm said. Terms of the agreement give Sanbio exclusive right to market and sell the panel in the
Tm "intend[s] to complete a series of distribution agreements across Europe over the coming months to be well positioned for the rapid commercialization of this test upon gaining European regulatory clearance, which we anticipate will be achieved in 2006," Tm President and CEO Greg Hines said in a statement.